These data suggest that Bfl-1 might play a role in gemcitabine resistance of lung cancer cells, and that the down-regulation of Bfl-1, either directly or using BC, offers an effective means of making lung cancer cells sensitive to gemcitabine. The gene discussed is BCL2A1; the disease is lung cancer.